Personal Information
Entreprise/Lieu de travail
Greater New York City Area, PA United States
Profession
Vice President - Life Sciences
Secteur d’activité
Apparel / Fashion
Site Web
http://www.stemcellcapital.com
À propos
Senior life sciences industry professional with >15 yrs of global diversified experience covering biopharma R&D, digital health, mobile analytics, corporate strategy, management consulting, investment banking, corporate development (BD&L, partnering & alliances) and operations.
Experience working with the world's finest organizations such as Dana-Farber/Harvard Cancer Center, Booz & Co., Takeda Oncology, Astellas Pharma, Roche Ventana/BioImagene, Avendus Capital, Cold Spring Harbor Laboratory, Piramal Enterprises, and others. Proven leadership qualities having established, led and grown companies and built high-performing teams globally, winning and managing Fortune 500 and top-tier cli...
Mots-clés
buyout
m&a
pharma
russia
inorganic growth
usa
india
jv
biotech
gmp
acquisitions
generics market
multiples
contract research
manufacturing
Tout plus
Présentations
(4)Documents
(1)Personal Information
Entreprise/Lieu de travail
Greater New York City Area, PA United States
Profession
Vice President - Life Sciences
Secteur d’activité
Apparel / Fashion
Site Web
http://www.stemcellcapital.com
À propos
Senior life sciences industry professional with >15 yrs of global diversified experience covering biopharma R&D, digital health, mobile analytics, corporate strategy, management consulting, investment banking, corporate development (BD&L, partnering & alliances) and operations.
Experience working with the world's finest organizations such as Dana-Farber/Harvard Cancer Center, Booz & Co., Takeda Oncology, Astellas Pharma, Roche Ventana/BioImagene, Avendus Capital, Cold Spring Harbor Laboratory, Piramal Enterprises, and others. Proven leadership qualities having established, led and grown companies and built high-performing teams globally, winning and managing Fortune 500 and top-tier cli...
Mots-clés
buyout
m&a
pharma
russia
inorganic growth
usa
india
jv
biotech
gmp
acquisitions
generics market
multiples
contract research
manufacturing
Tout plus